Congratulations to Dr. Athanasios Zovoilis and his team on receiving a Manitoba Solutions Grant from Research Manitoba. AI4Omicw-MB will explore how AI can be applied to genetic data from Manitoba patients to support earlier cancer detection and more personalized treatment in cancer care.

Congratulations to Dr. Ryan Zarychanski on being awarded a Tier 1 Canada Research Chair in Clinical Trials. This prestigious recognition is awarded to researchers who are internationally recognized leaders in their field and conducting groundbreaking research with significant impact. #cancerresearch

At CCMB, nearly 900 doses of injectable treatments are carefully prepared each week inside a specialized “clean room”. With over 8,000 Manitobans diagnosed with cancer each year, our teams are working together to ensure patients receive the right care, closer to home. www.cbc.ca/news/canada/...

The TRACTION trial—co-led by CancerCare Manitoba researchers presented yesterday at #ASH2025. Findings from 8,400 patients show pre-op tranexamic acid reduces blood transfusion with no increase in blood clots, even in cancer patients. A major step towards safer surgeries and sustainable blood supply

A recent study from our team confirms that isatuximab, a common myeloma treatment— can now be safely delivered in just 30 minutes instead of 75 minutes. Why it matters: quicker appointments, more comfortable experiences, and more capacity to care for Manitobans. #patientcare #cancercare

🎓 Exciting news! #PROMISE Madox's Warriors Graduate Studentship officially launches today! Check out the details and help spread the word. #MadoxsWarriors #GradStudentship #CHRIM #CCMB #CancerResearch @um-radyfhs.bsky.social @umbmg.bsky.social @cancercaremb.bsky.social @chrimanitoba.bsky.social

🍁Meet the Team Canada of Cancer Research: A Q&A with Dr. Versha Banerji🍁 After early setbacks, Dr. Banerji found her calling in hematology. Through MOHCCN, she and her team study immune dysfunction in chronic lymphocytic leukemia to develop more targeted cancer therapies. tinyurl.com/bdf7w8cv

We are pleased to welcome Dr. Kent Stobart as CancerCare Manitoba’s new President and CEO. A pediatric oncologist and a health care leader, Dr. Stobart brings passion, experience, and a commitment to advancing cancer care and research for all Manitobans. 💙